Material
I mmune homeostasis and maintenance of self-tolerance depends upon constant vigilance by CD4 + Foxp3 + regulatory T cells (Treg). Commitment to the Treg lineage occurs primarily in the thymus (1, 2) , but also in the periphery in a TGFb-dependent manner (3) (4) (5) (6) . One of the major goals of modern immunosuppression, be it in autoimmune disease or transplantation, is to harness tolerance mechanisms such as those used by Treg to minimize the duration and extent of drug immunosuppression. Short-term coreceptor blockade provided the first demonstration that induction of tolerance could be achieved using lowimpact intervention in a mature immune system (7) . Studied in a transplantation setting, this form of tolerance is totally dependent on the ability of TGF-b to signal to T cells (6) and is also associated with de novo induction of Ag specific Foxp3 + induced Treg (iTreg) (4, 8) . This raises the possibility that the absolute need for TGF-b is simply to guarantee conversion of naive CD4 + T cells to stable Foxp3 expression.
However, TGF-b signaling not only induces expression of Foxp3, but also many other effector molecules, including CD39, CD73, CTLA4, CD103, neuropilin, perforin, and IL-10 (9-12). There are also claims that TGF-b is needed for the effector arm of suppression (13) , and if so, this, too, could explain the need for TGF-b signaling to T cells.
Despite a large literature on Foxp3 + Treg in self-tolerance, it is not known whether Foxp3 expression is essential for dominant tolerance induced to foreign Ags or whether other genetic/ expression modalities (e.g., those potentially necessary for Th3, Tr1, and iTr35 cells) can operate in its absence. Using a combination of genetically manipulated mouse strains unable to express Foxp3, retroviral constructs facilitating conditional nuclear localization of Foxp3, and a dominant-negative TGF-bRII to ablate TGF-b signaling in T cells, we have addressed the contributions of TGF-b and Foxp3 to the induction and function of iTreg. We show that Foxp3 expression is indispensible for tolerance induction to transplanted tissue, and its continued nuclear expression is necessary for maintenance of tolerance. In contrast, once tolerance is established, prevention of tissue damage does not depend on TGFb signaling to naive T cells. This indicates that the major role of TGF-b in this form of acquired tolerance largely resides in the induction of Foxp3 expression in naive CD4 + T cells. Comparative transcriptome analysis of in vitro-generated, TGF-b-experienced
Foxp3
+ and Foxp3 2 CD4 + T cells with TGF-b-experienced Foxp3 2/2 CD4 + T cells not only confirms TGF-b signaling in all the populations, but also demonstrates that, although crucial for maintenance of tolerance, the proportion of the transcriptome controlled specifically by Foxp3 in iTreg appears to be relatively limited.
Materials and Methods

Experimental animals
CBA/Ca (CBA), C57BL/6J (B6), CBA. , and Marilyn.CD4-dnTGFbRII.Rag1 2/2 mice were bred and maintained under specific pathogen-free conditions at the Sir William Dunn School of Pathology (University of Oxford, Oxford, U.K.). CD4-dnTGFbRII mice backcrossed to B6 for .10 generations were crossed with B6.Rag1 2/2 mice for two generations to generate CD4-dnTGFbRII.Rag1 2/2 animals, which were further crossed with Marilyn mice to introduce the Dby-H2A b specific TCR-transgenic element. All experimental procedures received local ethics committee approval and were conducted in accordance with the Home Office Animals (Scientific Procedures) Act of 1986.
Skin grafting
Skin grafting was performed as described previously (16) . Maintenance of nuclear Foxp3 in cFoxp3-transduced T cells adoptively transferred into mice was enforced by daily i.p. injections of tamoxifen in sunflower oil (1 mg daily).
Abs
Anti-CD4 (L3T4), anti-CD25 (7D4), and anti-CTLA4 (BN13) were purchased from BD Biosciences. Anti-Foxp3 (FJK-16s), anti-CD39 (24DMS1), and anti-CD73 (TY/11.8) were purchased from eBioscience. Anti-GITR (YGITR-765) was purchased from Serotec.
Cytokines for cell culture and synthetic peptides
Lyophilized recombinant human TGF-b1 was purchased from R&D Systems and reconstituted to 10 mg/ml in 4 mM HCl containing 1 mg/ml BSA. Lyophilized peptide HYA b (NAGFNSNRANSSRSS) (14) was reconstituted in PBS and used at a maximum working concentration of 100 nM.
Bone marrow-derived dendritic cell preparation
Bone marrow-derived dendritic cells (BMDCs) were prepared as described previously (17) . Murine GM-CSF-enriched supernatant was harvested from the transfected cell line X63 (provided by D. Gray, Edinburgh, Scotland) and used at an equivalent of 5 ng/ml.
CD4 + T cell preparation
Splenic CBA or B6 CD4 + T cells were isolated by negative selection using an AutoMACS CD4 + T cell isolation kit and AutoMACS separator (Miltenyi Biotec).
In vitro generation of iTreg
RBC-depleted splenocytes from Marilyn, Marilyn.Foxp3 hCD2 , and Marilyn. Foxp3 2/2 mice were cultured at a 5:1 ratio with mitomycin-treated B6 female BMDCs in RPMI 1640 containing 100 nm HYA b peptide for 7 d. For TGF-b-conditioned iTreg cultures, recombinant human TGF-b was also added at 2 ng/ml. Foxp3 expression was typically 50-90% for TGFb-conditioned cultures (i.e., 50-90% of TGF-b-conditioned cultures were Foxp3 + iTregs). For microarray analysis, MoFlo sorting (DakoCytomation, Glostrup, Denmark) was employed to sort Foxp3 + and negative cells from the cultures based on human CD2 (hCD2) expression.
FACS
Cells were washed twice in PBS containing 0.5% w/v BSA and incubated for 10 min at room temperature in PBS with 10 mg/ml anti-FcR block (2.4G2) and then with primary Ab for 30 min in the dark at 4˚C. Following washing and fixation with 2% paraformaldehyde, analysis was performed on an FACSCalibur (BD Biosciences) with dual laser excitation (488 and 633 nm). Data acquisition was performed with interchannel compensation using CellQuest version 3.1 software (BD Biosciences) and data analysis performed with FlowJo 7.2.4 software (Tree Star). Foxp3 staining was performed using a commercial kit (eBioscience) according to the manufacturer's directions.
MoFlo FACS sorting of cells
Flow cytometry sorting was performed using a MoFlo sorter (DakoCytomation).
Production of conditional Foxp3 retroviral supernatant
All vectors used except pCL-ECO have previously been described (18) . The conditional Foxp3 construct cFoxp3 was made by cloning sequenceencoding ERT2, a modified estrogen-binding domain, in-frame with the C terminus of Foxp3. GFP coding sequence was cloned directly after the fifth codon of Foxp3 to produce the fusion protein GFP-Foxp-ERT2. This was then cloned into a Moloney murine leukemia virus backbone, a circular plasmid that also contained a GPI-linked and internal ribosome entry site-driven rat CD8a (rCD8) gene. The empty control vector contained only the GFP and rCD8 segments, but no Foxp3. The packaging vector, pCL-ECO, was purchased from Addgene (Cambridge, MA). The day before transfection, a confluent plate of HEK 293eT cells were split at one in three and plated in six-well plates at ∼40% confluency, with 2 ml/well. Approximately 16 h later, the cells were transfected with 2 mg pCL-ECO packaging plasmid and 2 mg retroviral vector cFoxp3 using the CaCl 2 method. Six hours after transfection, the medium in the well was replaced with fresh medium. A further 24 h later, the viral supernatant was harvested and filtered through a 0.45-mm filter. Protamine sulfate (600 mg/ml) was added to the viral supernatant.
Retroviral transduction of CD4 + T cells
AutoMACS-sorted CD4 + cells were cultured at 2 3 10 5 /well in a 96-well plate precoated with anti-CD3 (KT3; 4 mg/ml in PBS, 1 h at 37˚C). The cells were activated for 24 h and then resuspended in a 1:2 mixture of viral supernatant and complete medium (IMDM containing 10% v/v FCS and 10 mM 2-ME). This mix was supplemented with 5 ng/ml recombinant murine IL-2 (PeproTech) and 5 ng/ml recombinant murine IL-7 (PeproTech). This was followed by centrifugation at 500 3 g for 2 h at 32˚C. Cells were analyzed 40 h later. Typical transduction efficiencies were 30-50%. Following transduction, in most experiments, the cells were MoFlo sorted (DakoCytomation) to achieve 99.9% GFP-positive cells, as indicated in figure legends. For induction of nuclear localization of Foxp3, transduced cells were cultured in the presence of 50 nM of 49hydroxy-tamoxifen (4HT) for at least 24 h.
Confocal microscopy
Confocal microscopy was performed on a Zeiss LSM 510 META laser scanning microscope (Carl Zeiss MicroImaging, Gö ttingen, Germany) using a 320 objective.
Cytokine measurement
A 23-component multiplex bead-based assay specific for eotaxin, G-CSF, GM-CSF, IFN-g, IL-1a, IL-1b, IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12p40, IL-12p70, IL-13, IL-17, eotaxin, keratinocyte chemoattractant, MCP-1, MIP-1a, MIP-1b, RANTES, and TNF-a (Bio-Rad) was used according to the manufacturer's recommended protocol and samples analyzed using a Bio-Plex System and Bio-Plex Manager Software 4.0 (BioRad). 
Proliferation and suppression assays
Statistical analysis
Statistical significance was determined using one-way ANOVA tests with Dunnett's multiple comparison posttest or Student t test (unpaired, twotailed) using GraphPad Prism software (http://www.graphpad.com; GraphPad). In the figures, *p , 0.05, **p , 0.01, and ***p , 0.001.
Results
Foxp3 expression is required for induction of transplantation tolerance mediated by coreceptor blockade
It is well established that T cells expressing Foxp3 are critical for maintenance of tolerance to self-Ags. The requirement for Foxp3 in the induction of peripheral tolerance to foreign Ags has not, however, been unequivocally demonstrated. It is possible that other cell types such as Th3, Tr1, or iTr35 might emerge and operate in its absence. Transplantation tolerance can be induced in TCR-transgenic mice lacking natural Treg (nTreg). This is associated with the development of Foxp3 + iTreg in the periphery. It cannot be induced, however, if TGF-b signaling to T cells is prevented (6) . We asked if alternative routes to tolerance might engage in a situation in which Foxp3 induction was prevented by genetic ablation, but in which TGF-b signaling pathways were left intact. To address this in circumstances in which autoimmune pathology could be avoided, we generated + iTreg in Marilyn mice (8) . As expected, the majority of the Foxp3-sufficient mice accepted their male grafts indefinitely, whereas all of the Marilyn.Foxp3 2/2 mice had rejected their grafts by 60 d (Fig. 1A) . Thus, the tolerance induced by shortterm coreceptor blockade requires a functional Foxp3 gene, despite an intact TGF-b signaling axis.
TGF-b-driven in vitro-generated iTreg require Foxp3 expression to become rejection incompetent TGF-b induces potent anti-inflammatory adenosine production by CD4 + T cells via cell-surface-expressed CD39 and CD73 ectonucleotidase activity (9) . Regulation of these enzymes is independent of Foxp3 expression, and it has been suggested may confer suppressive activity in the absence of Foxp3 (19) . We asked whether TGF-b-conditioned T cells might still be able to suppress rejection of grafts if they could not express Foxp3 and also whether TGF-b was required as a mechanism of suppression. We generated sets of TGF-b-conditioned T cells in vitro by stimulating Marilyn or Marilyn. animals rejected their grafts within the same rapid time frame as that of wild-type Ag-activated but non-TGF-b-experienced (Foxp3-negative) splenocytes (Fig. 1C) . Even as few as 4 3 10 4 HYT Marilyn.Foxp3 2/2 cells were still able to reject male skin grafts at the same rate as 1 3 10 6 cells (Fig. 1D) . In short, TGF-b conditioning in the absence of Foxp3 expression has little impact on the ability of the T cells to reject grafts, showing the critical role of Foxp3 in extinguishing that function and thus ruling out a major role for alternative TGF-b-induced pathways [such as adenosine generation (9)] in iTreg-induced long-term graft acceptance in this setting.
The true role for TGF-b in Treg-mediated suppression is controversial, with studies arguing for and against its requirement. We have previously shown that TGF-b signaling to T cells is essential for the development of dominant tolerance (6) . To establish whether in this case TGF-b was operating in the inductive phase of tolerance or at a later stage to sustain dominant tolerance, female Marilyn mice were made tolerant to male B6. Rag 2/2 skin using anti-CD4 Ab treatment. On regrafting at 95-120 d after the first graft, the tolerized mice also received 1 3 10 6 rejection-competent CD4 + T cells from either female Marilyn or female Marilyn.dnTGFbRII mice. In both cases, the mice were able to resist rejection by the transferred cells (Fig.  1E) , demonstrating that TGF-b signaling to T cells was not essential for suppression of rejection once regulatory T cells had been induced.
CD4
+ T cells that fail to convert to Foxp3 + in the presence of TGF-b remain able to secrete proinflammatory cytokines (Fig. 3A) . A total of 3046 transcripts were found differentially expressed at p , 0.01 (Supplemental Table I 3C ). The high correlation (R 2 = 0.61) suggested that there was not a significant additional detectable effect, positive or negative, from the genomic copies of Foxp3. Thus, the TGF-b signature seems to be independent of Foxp3. These data also show that loss of Foxp3 was not inhibiting TGF-b responsiveness of these cells.
Samples of the TGF-b-treated and -untreated, sorted hCD2 + and hCD2 2 groups exhibited the expected relative level of Foxp3 transcript expression (Fig. 4A ). To identify a TGF-b-induced Foxp3 effect between the two sorted, TGF-b-influenced groups (HYT hCD2 + and HYT hCD2 2 ), a comparative analysis was first carried out to identify transcripts differentially expressed between the two populations. A total of 183 transcripts (p , 0.01) were The Journal of Immunologyfound differentially expressed (Fig. 4B, 4C , Supplemental Table  III) . Among them, a subset of 34 transcripts was then identified as uniquely associated with the TGF-b-induced hCD2 + cells (Fig.  4C , indicated in blue, orange, and turquoise). Finally, upon further eliminating general TGF-b effects, 27 transcripts were considered to comprise a unique TGF-b-induced-Foxp3 signature (Fig. 5A , 5B).
Ectopic tamoxifen-mediated nuclear localization of Foxp3 imposes a suppressive phenotype onto naive T cells
Our demonstration that Foxp3 was indispensible for tolerance induced by TGF-b led us to ask whether the need for Foxp3 expression in tolerance was transient or sustained. Many groups have demonstrated that ectopic expression of Foxp3 leads to suppressive function, and in vitro cre-lox deletion of Foxp3 has been shown to reverse the suppressive properties of Treg. However, it is not known whether iTreg need to express Foxp3 for prolonged periods in order for tolerance to be maintained nor what effect turning off Foxp3 in vivo following tolerance induction would have. For example, Foxp3-influenced T cells may, over time, acquire suppressive features that are Foxp3 independent. We therefore asked two questions: namely, is prolonged Foxp3 expression needed for iTreg to remain rejection incompetent, and is continuous Foxp3 expression required for iTreg to retain their suppressive ability? To address these questions, we used a retroviral construct, cFoxp3, encoding a fusion protein GFP-Foxp-ERT2, for which entry to the nucleus, and therefore Foxp3 activity, requires addition of tamoxifen (18) (see Materials and Methods). We first established the ability of the construct to translocate to the nucleus following tamoxifen treatment and to induce attributes consistent with a Treg phenotype, namely anergy, upregulation of Treg cell-surface markers, and suppression of proinflammatory cytokine production (Fig. 6) . We showed that after 64 h, GFP-Foxp3 fusion protein had clearly translocated into the nuclei of .95% of transduced AutoMACS-sorted CD4 + splenocytes, FACS-sorted for GFP and treated with 4HT, but remained predominantly cytoplasmic in transduced but noninduced cells (Fig. 6A, 6B) . Tamoxifen exposure rendered the T cells anergic (Fig. 6C ) and was associated with upregulation of the Treg-associated surface markers CTLA4, CD25, and GITR (Fig. 6D) . Foxp3 negatively regulates transcription of many cytokines (20, 21) , and we found that 4HT-treated transduced T cells also secreted minimal quantities of proinflammatory cytokines, such as IL-1, IL-2, IFN-g, IL-4, IL-9, and IL-17, when compared with cells transduced with empty vector or with cFoxp3, but without 4HT treatment (Fig. 7) . We term such transduced cells induced to exhibit a regulatory phenotype by using 4HT as conditional Treg (cTreg).
Persistent nuclear expression of Foxp3 is required for cTreg to remain rejection incompetent
We next tested whether, in the absence of exogenous addition of TGF-b, tamoxifen exposure would suffice to render T cells unable to reject grafts. Naive Marilyn CD4 + T cells, which do not express Foxp3, were transduced with cFoxp3; half were treated and half untreated with 4HT for 2 d in vitro to induce nuclear localization of the GFP-Foxp-ERT2 fusion protein. 
Sustained Foxp3 expression is needed to maintain a suppressive phenotype
In order to establish whether sustained expression of Foxp3 in cTreg was needed for their suppressive function, immunecompetent naive female Marilyn mice, which lack endogenous Treg, were adoptively transferred with 5 3 10 5 transduced Marilyn, 4HT-treated cTreg (Fig. 8C, 8D) . The mice were then grafted with a male CBA.Rag 
Discussion
We had set out to test the extent to which induction of Foxp3 expression explained the need for TGF-b signaling to T cells in eliciting tolerance to transplanted tissues (6 mice, and microarray analysis to demonstrate that although the number of genes affected by TGF-b exposure is large, the set of genes in iTreg for which expression is correlated specifically with Foxp3 expression is surprisingly low. Finally, ectopic inducible nuclear Foxp3 expression was used to demonstrate that continuous expression of Foxp3 on a per-cell basis was required for maintenance of induced tolerance. We present five novel findings. First, the potential to express Foxp3 is essential for this form of induced peripheral tolerance. Second, a TGF-b experience in the absence of Foxp3 is insufficient for tolerance despite inducing a significant TGF-b gene signature. Third, TGF-b signaling to T cells, although essential for induction of tolerance, is not essential for suppression by iTreg. Fourth, sustained functional expression of Foxp3 in vivo is necessary to ensure prolonged graft survival. Fifth, iTreg have independent TGF-b and Foxp3 gene signatures, the latter consisting of a relatively small number of genes. The literature describes many different CD4 + T cell subsets exhibiting regulatory properties. These include TGF-b-secreting Th3 cells (22, 23) , IL-10-secreting Tr1 cells (24) , and IL-35-secreting iTr35 cells (25) . We have previously shown that maintenance of tolerated allogeneic skin grafts required constant suppression by Foxp3 + cells (8) . In this study, we show for the first time, to our knowledge, that Foxp3 expression is essential for the induction of tolerance. Any other potentially suppressive mechanisms such as Tr1 cells did not emerge as effective substitutes for Foxp3 + T cells. In Marilyn mice, tolerance by coreceptor blockade relies on the TGF-b-dependent de novo differentiation of iTreg (6) . We propose, therefore, that failure to induce tolerance in the Marilyn. It is still unclear whether iTreg play a major role in the control of immune homeostasis. Numerous studies have shown that Foxp3 + iTreg can arise in a number of experimental settings. These include exposure of T cells to cognate Ag in the absence of microbial or endogenous danger signals as in the case of mucosally (26), as well as parenterally delivered Ags (27) . It has, however, been difficult to separate the need for nTreg away from that for iTreg in experimental models. Whatever emerges as the normal physiological role for iTreg, it is clear that they play a crucial role in therapeutic tolerance in TCR-transgenic mice, as demonstrated in this study. This coupled with the absolute need for TGF-b signaling to T cells for transplantation tolerance in conventional mice suggests that iTreg are also very relevant in that context. Foxp3 has been shown to have binding regions on ∼700 genes in nTreg, as well as forming a supramolecular complex with other transcription factors and chromatin modifiers (21) . Persistent Foxp3 expression is likely needed to maintain the transcriptional changes and epigenetic alterations of target genes that it controls. We performed extensive transcript analysis using exon tiling microarrays and demonstrated that T cells have ∼3000 transcripts significantly altered in expression by TGF-b. However, subtractive comparisons of the transcriptome of TGFb-experienced T cells that did not convert to Foxp3 expression (HYT CD4 + hCD2 2 cells from Marilyn.Foxp3 hCD2 ) or TGFb-experienced Foxp3 2/2 CD4 + T cells showed a very limited signature of 27 genes influenced solely by Foxp3 in iTreg. Thus, although Foxp3 can bind hundreds of genes in thymically derived Treg, resulting in up and down gene regulation, in our populations of iTreg, the number of genes significantly altered in expression by Foxp3 was much more limited. Foxp3 expression is controlled in part by variable DNA methylation at the Tregspecific demethylated region (28, 29) . The transcriptional and epigenetic modifications initiated by Foxp3 may not be sufficient to render the cell regulatory in the absence of continued Foxp3 expression. Cre-lox deletion of the Foxp3 gene in mature Treg was found to result in reversal of their regulatory characteristics and acquisition of ability to produce proinflammatory cytokines (30) . We have shown that sustained nuclear Foxp3 expression is required to maintain a cellular program compatible with regulation. For a regulatory cell to suppress, one desirable function would be that it limits its own production of proinflammatory cytokines. We observed such behavior for IL-1, IL-2, IL-4, IL-9, IL-17, and IFNg, all of which were reduced to low levels following tamoxifeninduced nuclear localization of GFP-Foxp3-ERT2 in cFoxp3-transduced Marilyn CD4 + T cells. The requirement for sustained suppression to maintain tolerance has already been argued where tolerance was lost when Foxp3-expressing cells were deleted (8, 31) . We have shown that simple withdrawal of tamoxifen in this system is sufficient to revert cTreg to an effector phenotype. Tamoxifen in an equivalent setting in human T cells has been shown to induce nuclear localization as well as increase the stability of the fusion protein (32) . Withdrawal of tamoxifen resulted in reversal of the inhibition of IFN-g production (32) . Thus, lowering the expression and changing the subcellular localization of Foxp3 from nucleus to cytoplasm is a potent switch to mediate loss of suppressive activity.
Two recent reports have shown that N-terminal addition of GFP to Foxp3 can alter the interaction of Foxp3 with HIF-1a, Eos, HDAC7, and TIP60, whereas interaction with NFAT is unaltered (33, 34) . This led to a decrease in proteasomal degradation of Foxp3 and subtle alterations of the genes inhibited by Foxp3. The result of these alterations was increased suppression of Th17 responses, resulting in increased susceptibility to diabetes on the NOD background, consistent with previous reports showing Th17 cells to be protective in this model. We have shown that Th17 cells mediate damage in allogeneic skin graft rejection (35) , thus the potency of our conditional Treg, which have an N-terminal GFP tagged Foxp3 may be explained in part by this phenomenon.
These studies reinforce and extend our earlier findings that 
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